SALT LAKE CITY, April 21, 2025 /PRNewswire/ — ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer’s disease (AD) pathology. As this biomarker can be detected in blood, this test is a minimally invasive and broadly accessible diagnostic tool that may facilitate earlier detection of AD.

Now, a team at EPFL’s Laboratory for Soft Bioelectronic Interfaces has developed a soft, thin-film ABI. The device uses micrometer-scale platinum electrodes embedded in silicone, forming a pliable array just a fraction of a millimeter thick.

Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.

BVI Medical announced that it received FDA 510(k) clearance for its Leos (laser endoscopy ophthalmic system) for treating glaucoma.

The body’s home-grown microbiota and bile acids could help boost the immune system to suppress tumor growth.

Researchers from Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have successfully employed an algorithm to identify potential mutations which increase disease risk in the noncoding regions of our DNA, which make up the vast majority of the human genome.

For millions of people around the world, asthma is more than just a breathing problem—it is a chronic and often debilitating condition caused by the immune system’s exaggerated response to harmless airborne particles.

High-intensity electrical pulses have been medically used to destroy tumors while sparing healthy tissue. But lower-intensity pulses may have a different effect—they reshape the battlefield, making tumors more vulnerable to the body’s own defenses.